Description
Captisol® is a derivatized beta cyclodextrin used in 16 FDA-approved products to date, including VEKLURY® (remdesivir) and KYPROLIS® (carfilzomib) to help solubilize & stabilize difficult-to-deliver molecules. Made by CyDex Pharmaceuticals (a Ligand Company), Captisol® is the leading pharmaceutical-grade sulfobutylether beta-cyclodextrin (SBECD), with an excellent record of safety and consistency.
Captisol® has been used in therapeutics across many routes of administration, including parenteral, oral, subcutaneous, ophthalmic, nasal, inhalation, and dermal. It is prepared by an all-aqueous process and distributed worldwide.
Contact us for technical specifications, a free sample, or formulation consultation to discover how Captisol® can advance your drug development program.